DurAVR™ has been implanted in 50 patients (44 with severe aortic stenosis and six valve-in-valve cases
to rectify prosthetic valve failure). Clinical results to date demonstrate this new class of biomimetic valve
outperforms the market leader, returning patients to a near normal haemodynamic (blood flow) state.
- Forums
- ASX - By Stock
- AVR
- Ann: Capital Raise
Ann: Capital Raise, page-5
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AVR (ASX) to my watchlist
(20min delay)
|
|||||
Last
$19.10 |
Change
0.090(0.47%) |
Mkt cap ! $367.1M |
Open | High | Low | Value | Volume |
$18.82 | $19.14 | $18.80 | $131.3K | 6.904K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 100 | $19.05 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$19.15 | 49 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 100 | 19.050 |
1 | 100 | 19.020 |
1 | 75 | 18.980 |
1 | 300 | 18.520 |
4 | 163 | 18.510 |
Price($) | Vol. | No. |
---|---|---|
19.150 | 49 | 1 |
19.200 | 567 | 1 |
19.250 | 125 | 1 |
19.500 | 1230 | 1 |
19.800 | 1000 | 1 |
Last trade - 15.59pm 05/06/2024 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
Previous Video
Next Video
SPONSORED BY The Market Online